Back to Agenda
Session 5 Track 2 - Communications: Plain Language Labeling in the Regulatory System: Consumer- and Patient- Centered Information
Session Chair(s)
Vratislav Hadrava, MD, PhD
Vice President and Medical Director, Global Innovative Products
Pfizer Canada, Inc., Canada
The Plain Language Labeling initiative is a part of the Canadian Regulatory Modernization. Its main objectives are improving safe and effective use of medicines, reducing preventable medication errors and supporting Canadians in making informed choices about their medications/health products. The labels also represent the key interface between the Canadian consumers and patients at one hand and Health Canada and the Manufacturers at the other hand. System wide collaboration is key to the success of this initiative. This session will review the key elements of the ongoing projects, explore their alignment with the needs of the Canadian public and other regulatory jurisdictions, and provide perspective of the Consumers/Patients, Health Canada and Industry.
Speaker(s)
Medication Incidents and Plain Language Labeling
Sylvia Hyland, RPh
Institute for Safe Medication Practices Canada, Canada
Vice President and Chief Operating Officer
Plain Language Labeling for Consumer Health Products
Robert B. White, MBA, MS, MSc
Consumer Health Products Canada, Canada
Director, Scientific & Regulatory Affairs
Update: Plain Language Labeling
Madeleine Marshall
Health Canada, Canada
Manager, Policy Division, Bureau of Policy, Science and International Programs
Have an account?